Back
HNRNPH2HGNC X-linkedPubMedPhenotypic expansion

Musculoskeletal Phenotypes of 19 Patients With X-Linked HNRNPH2-Related Neurodevelopmental Disorder: A Prospective Case Series.

Garcia A, Salazar R, Holuba N, et al.Am J Med Genet A 2026 · July 2026
Relevance score
5/10
Disease / domain
X-linked HNRNPH2-related neurodevelopmental disorder
Source
PubMed
PMID 42482495
Share on LinkedIn

Variant / mechanism

X-linked HNRNPH2-related neurodevelopmental disorder, whose musculoskeletal and orthopaedic manifestations had not previously been systematically described.

Summary

Detailed clinical phenotypes had already been reported for 33 individuals with X-linked HNRNPH2-related neurodevelopmental disorder, 75% of whom self-reported a musculoskeletal abnormality, but orthopaedic phenotypes, screening recommendations and treatment strategies had not been described. This prospective case series presents musculoskeletal and orthopaedic evaluations of 19 affected individuals, with standardised assessment of the spine, hips, knees, ankles and feet, together with imaging results. Pes planovalgus was noted in 17 individuals (89%), restricted hip extension in 9 (47%), reduced ankle dorsiflexion in 7 (37%), scoliosis in 4 (21%) and hip subluxation in 4 (21%). The authors propose screening and management recommendations based on these findings.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

No genetic novelty here, but useful characterisation work: the high frequency of foot and hip involvement justifies systematic orthopaedic assessment at follow-up, without waiting for functional complaints. Nineteen patients assessed at a single centre, with no comparator group, means these percentages should be read as orders of magnitude rather than penetrance rates. This is the kind of data that feeds multidisciplinary follow-up protocols rather than variant interpretation.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 1/3Evidence 2/3Novelty 1/2Sample 1/1Publication 0/1

Clinical impact: 1/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 0/1 → Total: 5/10

Keywords

HNRNPH2neurodevelopmental disordermusculoskeletalscoliosisorthopaedic follow-up

More articles on HNRNPH2

Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime